Concepedia

Katarina Färnegårdh

KF

8

Publications

590

Citations

8

H-Index

2001

Active since

Affiliations

Science for Life Laboratory(Current)

Karolinska Institutet

Stockholm University

SARomics Biostructures (Sweden)

KTH Royal Institute of Technology

Katarina Färnegårdh is an author at Science for Life Laboratory specializing in medicinal chemistry, molecular pharmacology, and drug discovery.

Top concepts

Publications per year

2001–2022

8

Publications

8

Osmium-Catalyzed Asymmetric Dihydroxylation of Olefins by H<sub>2</sub>O<sub>2</sub> Using a Biomimetic Flavin-Based Coupled Catalytic System

Sandra Y. Jonsson, Katarina Färnegårdh, Jan‐E. Bäckvall · Journal of the American Chemical Society · 2001 · 130 citations

, , +14

Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination

Nina Gustafsson, Katarina Färnegårdh, Nadilly Bonagas et al. · Nature Communications · 2018 · 124 citations · Full text

Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based Inhibitor

Robert Gustafsson, Ann‐Sofie Jemth, Nina Gustafsson et al. · Cancer Research · 2016 · 94 citations

Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress

Nadilly Bonagas, Nina Gustafsson, Martin Henriksson et al. · Nature Cancer · 2022 · 94 citations · Full text

A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

Marcus J.G.W. Ladds, Ingeborg M.M. van Leeuwen, Catherine J. Drummond et al. · Nature Communications · 2018 · 90 citations · Full text

Rows per page

1–5 of 8